4//SEC Filing
Tutewohl Steve 4
Accession 0001628908-21-000114
CIK 0001628908other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 5:52 PM ET
Size
26.0 KB
Accession
0001628908-21-000114
Insider Transaction Report
Form 4
Tutewohl Steve
Chief Operating Officer
Transactions
- Exercise/Conversion
Class A Common Stock Option (right to buy)
2021-08-02−3,331→ 20,114 totalExercise: $13.95Exp: 2028-02-01→ Class A Common Stock (3,331 underlying) - Exercise/Conversion
Class A Common Stock
2021-08-02$13.95/sh+3,331$46,467→ 117,434 total - Sale
Class A Common Stock
2021-08-02$23.02/sh−2,625$60,428→ 114,103 total - Exercise/Conversion
Class A Common Stock
2021-08-03$18.25/sh+11,229$204,929→ 125,332 total - Exercise/Conversion
Class A Common Stock Option (right to buy)
2021-08-03−11,229→ 0 totalExercise: $18.25Exp: 2027-02-01→ Class A Common Stock (11,229 underlying) - Sale
Class A Common Stock
2021-08-02$23.02/sh−3,331$76,680→ 114,103 total - Exercise/Conversion
Class A Common Stock
2021-08-02$18.25/sh+2,625$47,906→ 116,728 total - Exercise/Conversion
Class A Common Stock Option (right to buy)
2021-08-03−13,801→ 6,313 totalExercise: $13.95Exp: 2028-02-01→ Class A Common Stock (13,801 underlying) - Sale
Class A Common Stock
2021-08-03$23.02/sh−11,229$258,492→ 114,103 total - Exercise/Conversion
Class A Common Stock
2021-08-03$13.95/sh+13,801$192,524→ 127,904 total - Sale
Class A Common Stock
2021-08-03$23.02/sh−13,801$317,699→ 114,103 total - Exercise/Conversion
Class A Common Stock Option (right to buy)
2021-08-02−2,625→ 11,229 totalExercise: $18.25Exp: 2027-02-01→ Class A Common Stock (2,625 underlying)
Footnotes (9)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021.
- [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.13, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.99 to $23.13, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ 22.99 to $23.14, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.14, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The Class A Common Stock Options exercised vested on February 1, 2019.
- [F8]The Class A Common Stock Options exercised vested on February 1, 2018 and February 1, 2019.
- [F9]The Class A Common Stock Options exercised vested on February 1, 2019, February 1, 2020 and February 1, 2021.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeother
Related Parties
1- filerCIK 0001811845
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 5:52 PM ET
- Size
- 26.0 KB